DURECT Corporation (Nasdaq: DRRX) today announced that Gilead Sciences, Inc., (Gilead) has provided notice that, effective as of December 22, 2020, it is terminating the License Agreement dated July 19, 2019 Read More
Gilead Terminates License Agreement for Long-Acting Injectable HIV Investigational Product
Reading Time: < 1 minute